INMED PHARMACEUTICALS INC (INM) Stock Earnings & Estimates
NASDAQ:INM - CA4576377002 - Common Stock
2.22 USD
+0.04 (+1.83%)
2.16 USD
-0.06 (-2.7%)
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2022 | 2023 | 2024 | ||
|---|---|---|---|---|
| Revenue YoY % growth | 1.09M | 4.14M 279.82% | 4.598M 11.06% | |
| EBITDA YoY % growth | -13.4M -36.46% | -8.18M 38.96% | -7.915M 3.24% | |
| EBIT YoY % growth | -13.59M -36.72% | -8.38M 38.34% | -8.134M 2.93% | |
| Operating Margin | -1,246.79% | -202.42% | -176.92% | |
| EPS YoY % growth | -34.28 95.46% | N/A | N/A |
All data in USD
| EPS Q2Q % growth |
|---|
| Revenue Q2Q % growth |
| EBITDA Q2Q % growth |
| EBIT Q2Q % growth |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q4 2022 Q2Q % growth | -14.03 -36.88% | -5.56 | -8.48 | -152.57% |
| Q3 2022 Q2Q % growth | -6.25 39.02% | -6.31 | 0.06 | 0.99% |
| Q2 2022 Q2Q % growth | -7.75 24.39% | -5.93 | -1.82 | -30.61% |
| Q1 2022 Q2Q % growth | -6.25 -1,424.39% | -8.84 | 2.59 | 29.28% |
| Q4 2021 Q2Q % growth | -10.25 -2,400.00% | -8.59 | -1.66 | -19.39% |
| Q3 2021 Q2Q % growth | -10.25 | -6.06 | -4.19 | -69.14% |
| Q2 2021 Q2Q % growth | -10.25 | -6.06 | -4.19 | -69.14% |
| Q1 2021 Q2Q % growth | -0.41 | -6.06 | 5.65 | 93.23% |
| Q4 2020 Q2Q % growth | -0.41 | -6.06 | 5.65 | 93.23% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2025 Q2Q % growth | 1.26M 7.45% | % | ||
| Q2 2025 Q2Q % growth | 1.112M -10.35% | % | ||
| Q1 2025 Q2Q % growth | 1.265M 40.51% | % | ||
| Q4 2024 Q2Q % growth | 1.283M -44.45% | % | ||
| Q3 2024 Q2Q % growth | 1.173M 13.84% | % | ||
| Q2 2024 Q2Q % growth | 1.24M 163.83% | % | ||
| Q1 2024 Q2Q % growth | 900K 181.25% | % | ||
| Q4 2023 Q2Q % growth | 2.31M 352.94% | % | ||
| Q3 2023 Q2Q % growth | 1.03M 232.26% | % | ||
| Q2 2023 Q2Q % growth | 470K 74.07% | % | ||
| Q4 2022 Q2Q % growth | 510K | 757.5K | -247.5K | -32.67% |
| Q3 2022 Q2Q % growth | 310K | 606K | -296K | -48.84% |
| Q2 2022 Q2Q % growth | 270K | 126.25K | 143.75K | 113.86% |
| Q1 2022 Q2Q % growth | 252.5K | -252.5K | -100.00% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | N/A | N/A | N/A | N/A |
| Revenue | N/A | N/A | N/A | N/A |